FDAAugust 9, 2018drug

Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

Defective Container: Customer complaints of punctures in the bottle.

What to do

FDA enforcement status: Terminated

Brands named

orexigen therapeuticsorexigen

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →